India is launching a formal review of its 2011 trade agreement with Japan to address a $15.4 billion trade deficit and improve export access. While the nations look to unlock a 10 trillion yen investment pipeline, Indian exporters continue to face strict non-tariff hurdles in the Japanese market. The update is a key monitorable for sectors like pharmaceuticals and manufacturing that depend on smoother international trade.
India and Japan have officially initiated steps to modernize their 15-year-old Comprehensive Economic Partnership Agreement (CEPA), a move aimed at reshaping economic ties between the two nations. The decision follows high-level talks, including the 16th India-Japan Annual Summit held in July 2026, where leaders agreed that the 2011-era framework needs an update to remain relevant in the current global trade environment.
Addressing the Trade Imbalance
A primary driver for this review is the widening trade gap. In the 2025-26 fiscal year, bilateral trade between the two nations reached approximately $27.5 billion. However, India recorded a trade deficit of $15.4 billion, a figure that has caused concern among policymakers. By revisiting the terms of the agreement, the government aims to create a more balanced environment that allows Indian goods to compete more effectively in the Japanese market, rather than simply serving as a destination for Japanese imports.
Breaking Down Export Hurdles
For many Indian companies, the challenge has not been the lack of demand, but the presence of non-tariff barriers. Industry leaders, particularly in the pharmaceutical and food sectors, have reported that Japan’s strict quality, certification, and registration requirements are extremely difficult to navigate. These regulatory complexities act as silent barriers, effectively keeping competitive Indian products out of store shelves and hospital procurement lists in Japan.
Commerce Minister Piyush Goyal, who led a delegation of industry representatives to Japan in August 2026, has requested businesses to provide detailed reports on these specific hurdles. The government’s intent is to use these industry-specific insights during the upcoming negotiations to push for more practical certification processes. However, investors should note that negotiations of this scale are complex. Japan is unlikely to dismantle established safety and quality standards overnight, meaning the relief for exporters will likely depend on the specific terms of reference defined in the coming months.
A Massive Investment Pipeline
Beyond trade in goods, the partnership remains anchored by significant capital flows. Japanese firms have committed to a 10 trillion yen investment—over $62 billion—in India over the next decade. This capital is expected to flow into infrastructure, technology, and manufacturing projects. For investors, the success of the CEPA review is closely tied to how smoothly this money can be deployed.
Looking ahead, the market will focus on the progress of these negotiations. While the investment commitment provides a strong foundation for long-term growth, the immediate impact on equity markets will likely depend on whether the revised agreement can genuinely unlock market access for Indian exporters. Investors may track future updates on the terms of reference and management commentary from companies with significant exposure to the Japanese market.